Trial Profile
A Retrospective Study Evaluating the Development of Neovascular Age-Related Macular Degeneration (nAMD) in the Fellow Eye in Patients with Unilateral nAMD Treated by Treat-and-Extend Intravitreal Therapy with Aflibercept
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2018
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Polypoidal choroidal vasculopathy; Wet age-related macular degeneration
- Focus Therapeutic Use
- 18 May 2018 New trial record